- 1 سال پیش
- 33
- 07:39
8th Case: Intracranial Bleed
Daily cardiology
0
توضیحات
OAC Choice in High Thrombotic Risk Patients after ICH
کاربر شنوتو
اولین نفر کامنت بزار
- 28
- 1 سال پیش
Any Concerns for OACs Use in Patients with Thrombocytopenia
Any Concerns for OACs Use in Patients with Thrombo...
05:52
- 28
- 1 سال پیش
05:52
- 31
- 1 سال پیش
OAC of choice in patients with hepatic impairment, any difference between DOACs?
OAC of choice in patients with hepatic impairment,...
05:38
- 31
- 1 سال پیش
05:38
- 29
- 1 سال پیش
Low dose Rivaroxaban in SIHD, COMPASS trial
Low dose Rivaroxaban in SIHD, COMPASS trial
09:00
- 29
- 1 سال پیش
09:00
- 37
- 1 سال پیش
OAC choice in patients with obesity or low body weights, any role for DOACs?
OAC choice in patients with obesity or low body we...
09:33
- 37
- 1 سال پیش
09:33
- 39
- 1 سال پیش
OAC of choice in patients with artificial heart valves
OAC of choice in patients with artificial heart va...
11:30
- 39
- 1 سال پیش
11:30
- 39
- 1 سال پیش
Anticoagulation of choice in patients with cancer, the importance of DDI
Anticoagulation of choice in patients with cancer,...
12:58
- 39
- 1 سال پیش
12:58
- 43
- 1 سال پیش
Antithrombotic regimen of choice in patients with AF undergoing elective PCI
Antithrombotic regimen of choice in patients with ...
12:57
- 43
- 1 سال پیش
12:57
Endocrinologist Perspective on SGLT2 inhibitors
Endocrinologist Perspective on SGLT2 inhibitors
26:51
- 38
- 1 سال پیش
26:51
Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology
Role of SGLT2 inhibitors in HF patients from two p...
09:36
- 35
- 1 سال پیش
09:36
تمامی حقوق این وبسایت متعلق به شنوتو است